Module 5

Venom Biochemistry

Reptile venoms are an evolutionary pharmacology lab: thousands of independently-evolved peptide toxins targeting ion channels, receptors, the coagulation cascade, and vascular endothelium. This module reviews the two principal strategies — elapid α-neurotoxins and viperid hemotoxins — the deep Toxicofera origin of reptilian venom, the pharmacology of antivenom, and the repurposing of snake toxins as therapeutics.

1. Toxicofera — A Single Ancestral Venom System

Fry 2006 (Nature) used comparative transcriptomics to show that venom toxins in snakes, anguimorph lizards (Gila monster, beaded lizard) and iguanian lizards (some species) derive from the same ancestral gland system — the Toxicofera hypothesis. The ancestral venom was probably mild and adapted over ~170 My into the diverse pharmacopeias of modern elapids, viperids, and helodermatids.

Toxins share a small number of structural scaffolds — three-finger toxins (3FTx), Kunitz-type, phospholipase A₂ (PLA₂), metalloproteinase (SVMP), serine protease (SVSP), C-type lectin — that have been recruited and then duplicated into functional families via accelerated evolution at surface residues (Casewell 2013).

2. Elapid Neurotoxins

Elapidae (cobras, mambas, kraits, sea snakes) emphasise rapid paralysis. α-Neurotoxins are 3-finger polypeptides that bind irreversibly to muscle-type nicotinic acetylcholine receptors (nAChR) at the neuromuscular junction, producing flaccid paralysis and respiratory failure. α-bungarotoxin (Bungarus multicinctus) has K_d ≈ 10^-12 M — essentially irreversible — and has been the gold-standard nAChR probe in cellular neuroscience since Chang & Lee 1963.

\[ \text{nAChR} + \alpha\text{-Btx} \;\rightleftharpoons\; \text{nAChR-Btx},\quad K_d \sim 10^{-12}\text{ M} \]

β-neurotoxins (PLA₂-based, e.g., β-bungarotoxin, crotoxin) act presynaptically to prevent ACh release. Dendrotoxins (Kunitz-type, from mamba venom) block voltage-gated K⁺ channels in presynaptic terminals, producing neurotransmitter runaway. The net effect is the same lethal paralysis by three independent molecular routes.

Simulation: α-Bungarotoxin Kinetics

Steady-state receptor occupancy vs. toxin concentration and the time course of blockade at 1 nM — classical irreversible-binding kinetics with K_d ∼ pM.

Python

script.py44 lines

import numpy as np
import matplotlib
matplotlib.use('Agg')
import matplotlib.pyplot as plt

# Alpha-bungarotoxin binding at the neuromuscular junction
# nAChR receptors at NMJ follow Michaelis-Menten-like block
k_on  = 1e7                      # M^-1 s^-1
k_off = 1e-5                     # s^-1 (extremely slow - essentially irreversible)
Kd = k_off / k_on                # M

conc = np.logspace(-12, -6, 200)
frac_bound = conc / (Kd + conc)

# Time course at a fixed concentration
t = np.linspace(0, 600, 300)
C = 1e-9                         # 1 nM
occ = 1.0 - np.exp(-k_on*C*t)    # simple irreversible on-binding

fig, (ax1, ax2) = plt.subplots(1, 2, figsize=(14, 5), facecolor='#0a0a1a')
for ax in (ax1, ax2):
    ax.set_facecolor('#111827')
    ax.tick_params(colors='#cbd5e1')
    for s in ax.spines.values(): s.set_color('#334155')
    ax.grid(True, color='#334155', alpha=0.3)

ax1.semilogx(conc*1e9, frac_bound, color='#34d399', lw=2.5)
ax1.axvline(Kd*1e9, color='#fbbf24', ls='--', label=f'Kd = {Kd*1e9:.2g} nM')
ax1.set_xlabel('alpha-bungarotoxin (nM)', color='#cbd5e1')
ax1.set_ylabel('Fraction of nAChR blocked', color='#cbd5e1')
ax1.set_title('Irreversible nAChR blockade', color='#6ee7b7', fontweight='bold')
ax1.legend(facecolor='#1e293b', edgecolor='#334155', labelcolor='#cbd5e1')

ax2.plot(t, occ*100, color='#f87171', lw=2.4)
ax2.axhline(95, color='#fbbf24', ls='--', label='Paralysis threshold (~95%)')
ax2.set_xlabel('Time (s)', color='#cbd5e1')
ax2.set_ylabel('Percent nAChR blocked', color='#cbd5e1')
ax2.set_title(f'Time course at 1 nM toxin', color='#6ee7b7', fontweight='bold')
ax2.legend(facecolor='#1e293b', edgecolor='#334155', labelcolor='#cbd5e1')

plt.tight_layout()
plt.savefig('output.png', dpi=120, bbox_inches='tight', facecolor='#0a0a1a')
print(f'Kd ~ {Kd*1e9:.2g} nM (essentially irreversible)')
print(f'Time to 95% block at 1 nM toxin: {-np.log(0.05)/(k_on*C):.0f} s')

Click Run to execute the Python code

Code will be executed with Python 3 on the server

3. Viperid Hemotoxins

Viperidae (vipers, pit vipers, rattlesnakes) deploy a very different strategy: coagulopathy plus tissue destruction. Two enzyme families dominate:

Snake-venom metalloproteinases (SVMPs): zinc-dependent hydrolases that cleave basement-membrane type-IV collagen and fibrinogen, producing haemorrhage and disseminated intravascular coagulation. Jararhagin (Bothrops jararaca) is the prototype.
Snake-venom serine proteases (SVSPs): thrombin-like, fibrinogen-targeting enzymes. Ancrod (from Calloselasma rhodostoma) was historically used clinically as a defibrinogenating anticoagulant.

Additional components include PLA₂s that lyse erythrocytes and myocytes, C-type lectin-like proteins (CLPs) that perturb platelet function, and disintegrins — the peptide-scaffold inspiration for the α_IIbβ₃ antiplatelet drugs eptifibatide and tirofiban.

4. Antivenom & Clinical Management

Antivenom is produced by immunising horses (or sheep) with sublethal doses of venom, harvesting plasma, and purifying IgG (or F(ab’)₂fragments). The resulting polyclonal antibodies neutralise venom antigens by simple immunoprecipitation and FcR-mediated clearance. Antivenom is lifesaving but: (a) is polyspecific only within a narrow geographic envelope, (b) can provoke serum sickness or early anaphylaxis, and (c) is in chronically short supply in Sub-Saharan Africa and parts of Asia where snakebite is most common. Snakebite envenoming was formally added to the WHO list of Neglected Tropical Diseases in 2017.

Therapeutic repurposing of venom peptides is a growing pharmacopeia: captopril (from Bothrops jararacabradykinin-potentiating peptide) was the first ACE inhibitor; eptifibatide and tirofiban descend from disintegrins; exenatide (type-2 diabetes) is a Gila-monster GLP-1 analog.

Key References

• Fry, B. G. et al. (2006). “Early evolution of the venom system in lizards and snakes.” Nature, 439, 584–588.

• Casewell, N. R., Wüster, W., Vonk, F. J., Harrison, R. A. & Fry, B. G. (2013). “Complex cocktails: the evolutionary novelty of venoms.” Trends Ecol. Evol., 28, 219–229.

• Chang, C. C. & Lee, C. Y. (1963). “Isolation of neurotoxins from the venom of Bungarus multicinctus and their modes of neuromuscular blocking action.” Arch. Int. Pharmacodyn. Ther., 144, 241–257.

• Kini, R. M. (2003). “Excitement ahead: structure, function and mechanism of snake venom phospholipase A₂ enzymes.” Toxicon, 42, 827–840.

• Calvete, J. J. (2013). “Snake venomics: from the inventory of toxins to biology.” Toxicon, 75, 44–62.

• Gutierrez, J. M. et al. (2017). “Snakebite envenoming.” Nat. Rev. Dis. Primers, 3, 17063.

Share:X Reddit LinkedIn

← Module 4 Module 6: Reproduction →